Arterial stiffness progression in metabolic dysfunction-associated fatty liver disease subtypes: A prospective cohort study

被引:1
作者
Liu, Lei [1 ]
Zhou, Yufu
Deng, Shuwen [1 ]
Yuan, Ting [1 ]
Yang, Saiqi [1 ]
Zhu, Xiaoling [1 ]
Wang, Changfa [2 ]
Wang, Yaqin [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Hlth Management Ctr, Dept Gastroenterol, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp 3, Gen Surg Dept, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
关键词
Arterial stiffness; Brachial ankle pulse wave velocity (baPWV); Metabolic dysfunction-associated fatty liver (MAFLD); Diabetes; ASIA-PACIFIC REGION; CARDIOVASCULAR-DISEASE; RISK-FACTORS;
D O I
10.1016/j.numecd.2024.03.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: We aimed to investigate the correlation and to explore which MAFLD subtypes have the greatest influence on progression of arterial stiffness risk. Methods and results: Using data from a health examination-based cohort, a total of 12,129 participants who underwent two repeated health examinations that included brachial-ankle pulse wave velocity (baPWV) from 2012 to 2020 were enrolled. Participants were separated into non-MAFLD, overweight/obese (OW-MAFLD), lean/normal weight (lean-MAFLD) and diabetes (DM-MAFLD) groups. Among the participants with a median follow-up of 2.17 years, 4511 (37.2%) participants had MAFLD at baseline, among which 3954 (87.7%), 123 (2.7%), and 434 (9.6%) were OW-, lean- and DM-MAFLD, respectively. Analyses using linear regression models confirmed that compared with the non-MAFLD group, the elevated baPWV change rates (cm/s/ year) were 12.87 (8.81-16.94), 25.33 (7.84-42.83) and 38.49 (27.88-49.10) in OW, lean and DM -MAFLD, respectively, while the increased change proportions (%) were 1.53 (1.10-1.95), 3.56 (1.72-5.40) and 3.94 (2.82-5.05), respectively. Similar patterns were observed when these two baPWV parameters were transformed in the form of the greatest increase using Cox proportional hazards model analyses. Furthermore, the risk of arterial stiffness progression across MAFLD subtypes presented a significant, gradient, inverse relationship in the order of DM-, lean-, OW with metabolic abnormalities (MA)-, and OW without MA-MAFLD. Conclusion: MAFLD, especially DM-MAFLD and lean-MAFLD, was significantly associated with arterial stiffness progression, providing evidence that stratification screening and surveillance strategies for CVD risk have important clinical implications. (c) 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1890 / 1900
页数:11
相关论文
共 50 条
  • [21] Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study
    Lee, Seung Mi
    Cho, Geum Joon
    Wi, Won Young
    Norwitz, Errol R.
    Koo, Bo Kyung
    Lee, Jeesun
    Jung, Young Mi
    Kwak, Soo Heon
    Park, Chan-Wook
    Jun, Jong Kwan
    Joo, Sae Kyung
    Oh, Min-Jeong
    Kim, Won
    Park, Joong Shin
    [J]. HEPATOLOGY INTERNATIONAL, 2023, 17 (02) : 367 - 376
  • [22] Arterial stiffness as a complication of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
    Giannakodimos, Alexios
    Oikonomou, Evangelos
    Pantelidis, Panteleimon
    Theofilis, Panagiotis
    Katsiki, Niki
    Goliopoulou, Athina
    Zakynthinos, Georgios E.
    Korakas, Emmanouil
    Kalogera, Vasiliki
    Banach, Maciej
    Lampadiari, Vaia
    Kassi, Eva
    Ikonomidis, Ignatios
    Siasos, Gerasimos
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (04) : 413 - 426
  • [23] Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier
    Choudhury, Ashok
    Rajaram, Ruveena
    Sarin, Shiv Kumar
    [J]. HEPATOLOGY INTERNATIONAL, 2024, 18 (SUPPL 2) : 941 - 958
  • [24] Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study
    Hu, Qian
    Chen, Yao
    Bao, Ting
    Huang, Yan
    [J]. RENAL FAILURE, 2022, 44 (01) : 1996 - 2005
  • [25] Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study
    Sung, Ki-Chul
    Yoo, Tae Kyung
    Lee, Mi Yeon
    Byrne, Christopher D.
    Zheng, Ming-Hua
    Targher, Giovanni
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (03) : 482 - 491
  • [26] Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
    Shao, Congxiang
    Xu, Lishu
    Lei, Pingguang
    Wang, Wei
    Feng, Shiting
    Ye, Junzhao
    Zhong, Bihui
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [27] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    [J]. Hepatology International, 2023, 17 : 626 - 635
  • [28] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    [J]. HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [29] Impact of metabolic phenotype and alcohol consumption on mortality risk in metabolic dysfunction-associated fatty liver disease: a population-based cohort study
    Charatcharoenwitthaya, Phunchai
    Karaketklang, Khemajira
    Aekplakorn, Wichai
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] Non-alcoholic fatty liver disease is associated with progression of arterial stiffness
    Li, N.
    Zhang, G. -W.
    Zhang, J. -R.
    Jin, D.
    Li, Y.
    Liu, T.
    Wang, R. -T.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (02) : 218 - 223